Cardinal Health, Inc. (NYSE:CAH) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Cardinal Health, Inc. (NYSE:CAH) have received a consensus recommendation of “Moderate Buy” from the eighteen research firms that are currently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, fifteen have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $241.80.

A number of equities analysts have recently weighed in on CAH shares. Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Robert W. Baird set a $248.00 target price on Cardinal Health in a report on Friday, May 1st. JPMorgan Chase & Co. dropped their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a report on Monday, May 4th. Mizuho upped their target price on Cardinal Health from $222.00 to $235.00 and gave the company an “outperform” rating in a report on Friday, February 6th. Finally, Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th.

Hedge Funds Weigh In On Cardinal Health

Large investors have recently made changes to their positions in the business. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the 4th quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. acquired a new position in Cardinal Health in the fourth quarter worth approximately $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health in the fourth quarter worth approximately $27,000. Jones Financial Companies Lllp increased its holdings in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Finally, Palladiem LLC acquired a new position in Cardinal Health in the fourth quarter worth approximately $28,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Up 2.0%

CAH stock opened at $205.79 on Friday. Cardinal Health has a one year low of $137.75 and a one year high of $233.60. The firm has a market capitalization of $48.20 billion, a PE ratio of 31.47, a P/E/G ratio of 1.10 and a beta of 0.52. The firm has a 50-day moving average of $202.53 and a two-hundred day moving average of $208.57.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts anticipate that Cardinal Health will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.